strontium-89 chloride

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Hemat: anemia, neutropenia, thrombocytopenia

MS: transient increase in bone pain

Interactions ⬆ ⬇

Drug-drug:

Additive bone marrow toxicity with antineoplastics or previous radiation therapy.
Calcium-containing medications may ↓ bone uptake and effectiveness of strontium (discontinue 2 wk prior to strontium; may resume 2 wk after strontium).

Availability ⬆ ⬇

Radioactive injection: 10.9–22.6 mg/mL (148 megabecquerels or 4 millicuries) in 10-mL vials; 13.4–20.1 mg/mL (150 megabecquerels or 4.05 millicuries) in 10-mL vials

Route/Dosage ⬆ ⬇

IV (Adults ): 148 megabecquerels (4 millicuries) or 1.5–2.2 megabecquerels/kg (40–60 microcuries/kg), not to be repeated sooner than 90 days.

US Brand Names ⬆ ⬇

Action ⬆ ⬇

Preferentially taken up by bone tumors and metastatic bone lesions, where selective irradiation takes place.

Therapeutic effects:

Decreased pain from bony metastases. Because of delayed onset, adequate analgesia should be provided until effects of strontium are evident.

Classifications ⬆ ⬇

Therapeutic Classification: nonopioid analgesics

Pharmacologic Classification: radiopharmaceuticals

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability.

Distribution: Selectively localized in and retained by metastatic bone lesions. Excreted in breast milk.

Metabolism/Excretion: 67% excreted in urine, 33% in feces.

Half-Life: (physical half-life) 50.5 days.

Time/Action Profile ⬆ ⬇

(pain relief)

ROUTE	ONSET	PEAK	DURATION
IV	7–20 days	variable	6 mo (range 4–12 mo)

Patient/Family Teaching ⬆ ⬇

Instruct patient to continue taking pain medication until strontium-89 becomes effective. Analgesic doses may be decreased once the effects of strontium are known.
Advise patient that no change in eating or drinking is necessary. Alcohol and caffeine need not be avoided unless advised by health care professional.
Strontium-89 is present in the blood and urine for 1 wk following injection. During the 1st wk, the patient should be instructed to use a normal toilet rather than a urinal if possible and to flush twice after use. Spilled urine or blood from a cut should be wiped up with a tissue and flushed. Good handwashing should be observed, and any linen contaminated with blood or urine should be immediately washed separately from other items and rinsed thoroughly. If any urine collection device is used, the instructions on its use should be followed.
Instruct patient not to receive any vaccinations during therapy without consulting health care professional.
Instruct patient to notify any health care professional or caregiver of strontium-89 therapy prior to treatment.
Advise patient to contact health care professional if the effects of strontium-89 decrease and pain returns.
May cause infertility. Counsel patient prior to therapy. Advise female patients to notify health care professional immediately if pregnancy is planned or suspected, or if breastfeeding.
Emphasize the importance of periodic blood tests.